Duloxetine for the Treatment of Postpartum Depression
Status:
Withdrawn
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether the antidepressant, duloxetine, is equally
effective as a treatment for subjects who have a Postpartum Onset Depression compared to
subjects who have an onset of Major Depressive Disorder prior to delivery. The hypothesis is
that duloxetine will be as effective in subjects with Postpartum Major Depressive Disorder as
in subjects with a Major Depressive Disorder.